Previous Article | Next Article 
Journal of Clinical Microbiology, June 2000, p. 2292-2296, Vol. 38, No. 6
Department of Pathology, Section of Molecular Pathology,
University Hospital Vrije Universiteit,1 and
Institute for Research in Extramural
Medicine,2 Vrije Universiteit,
Department of Obstetrics and Gynecology, OLVG
Hospital,5 and Municipal Health
Service,6 Amsterdam, and STD Clinic,
Department of Dermatology, University
Hospital,3 and Regional Public Health
Laboratory,4 Groningen, The Netherlands
Received 14 January 2000/Returned for modification 11 March
2000/Accepted 8 April 2000
To determine whether certain Chlamydia trachomatis
serovars are preferentially associated with a symptomatic or an
asymptomatic course of infection, C. trachomatis serovar
distributions were analyzed in symptomatically and asymptomatically
infected persons. Furthermore, a possible association between C. trachomatis serovars and specific clinical symptoms was
investigated. C. trachomatis-positive urine specimens from
219 asymptomatically infected men and women were obtained from
population-based screening programs in Amsterdam. Two hundred
twenty-one C. trachomatis-positive cervical and urethral swabs from symptomatically and asymptomatically infected men and women
were obtained from several hospital-based departments. Serovars were
determined using PCR-based genotyping, i.e., restriction fragment
length polymorphism analysis of the nested-PCR-amplified omp1 gene. The most prevalent C. trachomatis
serovars, D, E, and F, showed no association with either a symptomatic
or asymptomatic course of infection. The most prominent differences
found were (i) the association of serovar Ga with symptoms in men
(P = 0.0027), specifically, dysuria
(P < 0.0001), and (ii) detection of serovar Ia more
often in asymptomatically infected people (men and women) (P = 0.035). Furthermore, in women, serovar K was
associated with vaginal discharge (P = 0.002) and
serovar variants were found only in women (P = 0.045).
Chlamydia trachomatis
infections are one of the leading causes of sexually transmitted
diseases (STDs) in the United States and Europe. Urogenital infections
with C. trachomatis in women have a clinical course varying
from asymptomatic C. trachomatis infections to ascending
infections leading to pelvic inflammatory disease associated with late
ectopic pregnancy and tubal infertility (15). In men,
urogenital C. trachomatis infection causes urethritis. Ascending infections (epididymitis) are rarely seen. C. trachomatis is an obligate intracellular bacterium, and so far, 19 different serovars have been identified. In addition to these 19 serovars, numerous variants have been characterized (6, 10,
21). Serovars A, B, Ba, and C infect mainly the conjunctiva;
serovars D, Da, E, F, G, Ga, H, I, Ia, J, and K are predominantly
isolated from the urogenital tract; and serovars L1, L2, L2a, and L3
can be found in the inguinal lymph nodes. Conventional serotyping is
performed after C. trachomatis culture using polyclonal and monoclonal antibodies against the major outer membrane protein of
C. trachomatis (1, 24, 25). The recently
developed method of direct PCR-based restriction fragment length
polymorphism (RFLP) analysis (genotyping of the omp1 gene,
which encodes the MOMP) of cervical and urethral swabs has partially
replaced the laborious and less sensitive serotyping technique (8,
14, 21, 27, 28). An increasing number of isolates have been typed
worldwide (2, 26, 31, 32, 35), transmission between sexual
partners has been studied, and geographical variation in the
distribution of serovars has been found (9, 13, 23). Some
studies have addressed the possible relationship between particular
serovars and clinical manifestations (31, 32). These studies
obtained contradictory results both for specific serovars, e.g., F and G, and for lower versus upper genital tract infections (4, 7, 11,
36). Furthermore, only a few studies have been published comparing the C. trachomatis serovar distribution in
asymptomatically infected persons, which comprise 70% of the C. trachomatis infections in women and 50% of those in men, with the
serovar distribution in symptomatically infected persons
(12).
Recently, commercially available DNA amplification systems were
introduced. They can be used successfully for detection of C. trachomatis in urine specimens from asymptomatically infected persons (16, 22, 29). Therefore, we have developed C. trachomatis typing of urine specimens to determine serovar
distribution in asymptomatically infected men and women
(20). Comparison of symptomatic and asymptomatic C. trachomatis infections at the serovar level could provide a better
understanding of the pathogenesis and epidemiology of urogenital
C. trachomatis infections.
The objective of this study was to compare C. trachomatis
serovar distributions between symptomatically and asymptomatically infected subjects to investigate a relationship between C. trachomatis serovars and the clinical course of infection.
Furthermore, a possible association between particular serovars and the
occurrence of clinical symptoms was studied.
Specimen collection.
Two different C. trachomatis-infected populations were used to collect 440 clinical
specimens for this study: an asymptomatic population of patients of
general practitioners (GPs) participating in a screening program (GP
based) and a hospital outpatient-based population (hospital based).
(i) Asymptomatically infected population.
Asymptomatically
C. trachomatis-infected persons (n = 219; 55 men and 164 women) were identified in a C. trachomatis
screening program in Amsterdam based on urine specimens which were
prospectively collected by GPs between May 1996 and October 1997 (30, 33). The screening program included only participants
between 15 and 40 years old.
(ii) Hospital outpatient-based C. trachomatis-infected population.
Included were female
cervical and male urethral swab specimens from C. trachomatis-infected persons (n = 250; 63 men and
187 women) collected between 1995 and 1999 at an outpatient clinical, an STD clinic, and a regional public health laboratory and between 1995 and 1998 at departments of gynecology and medical microbiology. During
the clinical examination, material was collected for C. trachomatis detection and participants were questioned about the reason for their visit. Symptomatically infected patients were defined
as those presenting with one or more genitourinary clinical symptoms
(men, urethral discharge and dysuria; women, abnormal vaginal
discharge, spotting, postcoital bleeding, dysuria, lower abdominal
pain, dysmenorrhoea, and dyspareunia). Asymptomatically infected
patients were defined as persons who did not contact a physician for
urogenital complaints but contacted a physician for a variety of other
reasons, including a C. trachomatis-positive partner or
ex-partner, pregnancy control, and C. trachomatis testing before intrauterine device insertion.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Urogenital Chlamydia trachomatis Serovars in Men and
Women with a Symptomatic or Asymptomatic Infection: an Association with
Clinical Manifestations?
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
C. trachomatis detection and typing. C. trachomatis was detected either by in-house PCR, by LCx (Abbott Laboratories, Chicago, Ill.), or by COBAS AMPLICOR (Roche Diagnostic Systems, Basel, Switzerland). Amplification was performed as described previously (18, 19) or in accordance with the instructions of the manufacturers.
From the original specimens (cervical and urethral swabs and urine specimens) and/or the remaining buffer-sample solutions (from LCs and AMPLICOR), DNA was isolated for typing by using a filter tube-based DNA isolation method (High Pure PCR Template Preparation Kit; Boehringer Mannheim, Mannheim, Germany) as described previously (20). C. trachomatis typing was performed by amplification of the omp1 gene (1.1 kb) in a nested PCR using primers NLO and NRO and primers sero1A and sero2A as described previously for cervical and urethral swabs (8, 14, 21) and urine specimens (20). The PCR product was checked on an agarose gel for length. Subsequently, 10 µl of the PCR product was digested using different restriction enzymes. Serovars and variants (21) were identified by their RFLP patterns after polyacrylamide gel electrophoresis.Statistical analysis.
Both patient characteristics (age and
gender) and clinical symptoms were analyzed for associations with
individual serovars or genogroups. For the latter, Chlamydia
serovars were classified in the following three groups (referred to as
genogroups) based on their nucleotide relatedness and serological
reactivity in previous studies (38): the B complex,
comprising serovars B, Ba, D, Da, D
, E, L1, and L2; the intermediate
genogroup or F/G group, comprising serovars F, G, and Ga; and the C
complex, comprising serovars C, H, I, I', Ia, J, K, and L3. The serovar
variants (unidentified PCR-based RFLP patterns) were defined as group
4. For statistical analysis, the chi-square test or the two-tailed
Fisher exact test was used. A P value of 0.05 was considered
statistically significant.
| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
C. trachomatis serovars and asymptomatic versus
symptomatic infection.
The distribution of serovars and its
relationship with either a symptomatic or an asymptomatic course of
infection are shown in Table 1. The
C. trachomatis serovar distribution in asymptomatically infected persons is for both GP-based and hospital-based persons, since
no statistically significant differences were found between these two
asymptomatic populations with regard to C. trachomatis serovar distribution (data not shown). In both men and women with C. trachomatis infection of the urogenital tract, serovars E
(39 and 44%, respectively), F (19 and 22%), and D/D (9 and 12%)
were the most common. These serovars accounted for 72 and 74% of the infections in men and women, respectively. The most prominent difference between symptomatic and asymptomatic men was the detection of serovar Ga in 14.3% of the symptomatically infected men versus 0%
in the asymptomatically infected men (P = 0.0027). This
also resulted in more symptomatically infected (43%) than
asymptomatically infected (23%) men in the intermediate genogroup
(F-G/Ga) (P = 0.033; Table 1). Furthermore, serovar Ia
comprised 3% of the C. trachomatis serovars and was found
only in asymptomatically infected people. The statistically significant
differences in serovar distribution are summarized in Table
2.
|
|
Serovars and specific clinical symptoms. Clinical symptoms were analyzed for possible associations with particular C. trachomatis serovars for both men and women. Serovar K was associated with vaginal discharge in women (P = 0.002), and serovar Ga was associated with dysuria in men (P < 0.001). For the possible relationship between serovars or genogroups and the number of clinical symptoms per subject, no statistically significant associations were found. However, a trend was found for both men and women with the lowest average number of symptoms per subject for group C (women versus men: genogroup B, 2.55 [125/53] versus 1.25 [25/20]; intermediate genogroup, 2.62 [68/26] versus 1.50 [27/18]; genogroup C, 2.22 [40/18] versus 1.00 [4/4]; variants, 1.67 [5/3] versus 0 [0/0]).
C. trachomatis serovars and gender. Serovar Ga was found more frequently in symptomatically infected men (14.3%) than in symptomatically infected women (1%) (P = 0.0028). Furthermore, variants (defined as unrecognizable PCR-based RFLP patterns after polyacrylamide gel electrophoresis) were found only in women (P = 0.045).
Multiple C. trachomatis infections. Two symptomatically infected women had multiple C. trachomatis infections (serovars E and J and serovars F and A). Since the group with multiple infections could not be analyzed separately due to its small size, it was excluded from further analysis.
Serovars and age. The mean ages of the patients included (between 15 and 40 years old) were 29.0 ± 7.2 years for men and 26.4 ± 6.1 years for women. When 5-year age groups between 15 and 40 years of age (15 to 19, 20 to 24, 25 to 29, 30 to 34, and 35 to 39 years old) were analyzed, women 15 to 19 years old were significantly more often symptomatically infected (15.5%) than asymptomatically infected (5.8%) (P = 0.0084; Table 2).
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
For the most prominent C. trachomatis serovars (D/D,
E, and F), which comprised 73% of the C. trachomatis
serovars, no associations were found between serovar, the presence or
absence of clinical symptoms, specific clinical symptoms, and gender.
However, differences were found for the less frequent C. trachomatis serovars Ga, Ia, and K: serovar Ga was associated with
dysuria in men, and serovar Ia was detected only in asymptomatically
infected men and women. Furthermore, serovar K was associated with the
specific clinical symptom abnormal vaginal discharge in women.
Our serovar distribution, with serovars D (D and D), E, and F the
most frequently observed serovars (73%), is in agreement with other
studies worldwide and in The Netherlands (31, 32, 34).
In this study, we found associations between C. trachomatis serovars and the clinical course of infection (asymptomatic versus symptomatic): serovar Ga was associated with a symptomatic infection in men (P = 0.0027). In contrast, Lan et al. (12) found that serovar G (no subdivision into G and Ga was made) seemed to be associated with symptomatic infection in women. Furthermore, serovar Ia was associated with asymptomatically infected men and women (P = 0.035). Also, in an other study, serovar I (no subdivision into I and Ia was made) was associated with asymptomatic infections (12). However, the association of serovar D with asymptomatic infections reported in that study could not be confirmed in this study.
In the present study, the association between serovars and specific
clinical symptoms was also investigated. We found that serovar Ga was
associated with dysuria in men (P < 0.0001). These results are in agreement with two previously published studies in which
an association was found between serovar G and symptoms in men,
although no subdivision into G and Ga was made (4, 12).
Furthermore, serovar F was found to be associated with urethritis in
that study (4). However, two other studies showed that
serovars F and G (no subdivision made) were not associated with
symptoms of urethral discharge and dysuria (31, 32) and fewer signs of inflammation among men infected with serovars G and Ga
were observed (32). Abnormal vaginal discharge was
associated with serovar K in women (P = 0.002) in our
study. Van Duynhoven et al. (32) reported that infections
with serovars D/D, H, and K seemed to be associated with
inflammation, as shown by the presence of 10 or more leukocytes,
although the association was not statistically significant. On the
other hand, van de Laar et al. (31) reported that serovars
from complex C exhibited somewhat less discharge but this was not
significant. Also, in our study, persons infected with the serovars in
complex C reported fewer symptoms but this was also not statistically significant.
Most studies investigating the association between C. trachomatis serovars and clinical symptoms of infection show contradictory results. This can be explained in part by geographical variations and differences in study size and population composition (1, 28). However, one should be aware that the differences found could be related to specific strains that cannot be distinguished at the serovar level. Perhaps genomic comparisons of serovars and strains could resolve the contradictory results found in the literature. Finally, host variation might also play an important role in the clinical course of infection and should be studied in more detail.
When C. trachomatis and gender are compared, three items are worth mentioning. Firstly, in this study, 13 C. trachomatis variants (5.6%) with an unrecognizable RFLP pattern were identified. These were all from women (P = 0.046). The percentage of variants found in our study is comparable to the 6.5% variants reported in an earlier study by our group (21). However, the true percentage of variants might be much higher, up to 35% for serovar E, if the complete omp1 gene were sequenced for all isolates (6). Interestingly, 10 out of 13 variants were isolated from asymptomatically infected women. Characterization of our variants by sequencing is in progress to see if specific variants are associated with the clinical course of infection. Secondly, both multiple infections were detected in two (2%) symptomatically infected women (these patients were excluded from further analysis). Other studies reported rates between 1 and 10% (3, 4, 5). However, a recent study detected multiple infections in 50% of men and 57% of women (17). Also, nucleotide sequencing of the omp1 gene showed higher rates, up to 15% (7, 37). Thirdly, there was an association between symptomatic C. trachomatis infections and age in women 15 to 19 years old. This preliminary association should be investigated in more detail.
The differences in C. trachomatis serovar distribution between asymptomatically infected women (mostly urine specimens [71%]) and symptomatically infected women (only cervical scrapes) could be biased by the different sampling sites used. However, this is unlikely, since identical serovars were found in cervical and urethral specimens from women as described in an earlier study by our group (20).
In conclusion, for the most prevalent C. trachomatis serovars, D, E, and F (73% of the serovars), no association was found with either a symptomatic or an asymptomatic course of infection. However, the less frequently occurring C. trachomatis serovars Ga and K were associated with specific clinical symptoms and serovar Ia was associated with asymptomatic C. trachomatis infections. It might be worthwhile to further investigate these serovars in connection with the presence or absence of clinical symptoms, possibly by investigation of virulence genes in these specific serovars.
| |
ACKNOWLEDGMENTS |
|---|
This work was partly supported by ZON (Prevention Fund, The Netherlands) grants 28-2588 and 28-1182-1.
We thank all of the general practitioners involved in the region of Amsterdam and all of the hospital personnel for collaboration and sample collection. We thank J. van der Lande and I. Melgers for patient file analysis and A. de Jong, T. Klop, R. Csordas, and R. M. Moes for excellent technical assistance in the typing of C. trachomatis serovars. Finally, we thank P. J. G. M. Rietra for sample collection and patient file analysis and D. S. Luijt and M. Buimer for coordinating sample collection.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Pathology, Section of Molecular Pathology, University Hospital Vrije Universiteit, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Phone: 31-20-4440503. Fax: 31-20-4442964. E-mail: vandenbrule{at}azvu.nl.
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
| 1. |
Barnes, R. C.,
S.-P. Wang,
C.-C. Kuo, and W. E. Stamm.
1985.
Rapid immunotyping of Chlamydia trachomatis with monoclonal antibodies in a solid-phase enzyme immunoassay.
J. Clin. Microbiol.
22:609-613 |
| 2. | Barnes, R. C., A. M. Rompalo, and W. E. Stamm. 1987. Comparison of Chlamydia trachomatis serovars causing rectal and cervical infections. J. Infect. Dis. 156:953-958[Medline]. |
| 3. | Barnes, R. C., R. J. Suchland, S. P. Wang, C. C. Kuo, and W. E. Stamm. 1985. Detection of multiple serovars of Chlamydia trachomatis in genital infections. J. Infect. Dis. 152:985-989[Medline]. |
| 4. | Batteiger, B. E., W. Lennington, W. J. Newhall, B. P. Katz, H. T. Morrison, and R. B. Jones. 1989. Correlation of infecting serovar and local inflammation in genital chlamydial infections. J. Infect. Dis. 160:332-336[Medline]. |
| 5. | Chunque, E., J. Soulier, G. Philippon, and S. P. Wang. 1994. Immunotypes of Chlamydia trachomatis isolated from genital tract specimens in Tahiti. Eur. J. Clin. Microbiol. Infect. Dis. 13:436-438[CrossRef][Medline]. |
| 6. | Dean, D., and K. Miller. 1997. Molecular and mutation trends analyses of omp1 alleles for serovar E of Chlamydia trachomatis. Implications for the immunopathogenesis of disease. J. Clin. Investig. 99:475-483[Medline]. |
| 7. | Dean, D., E. Oudens, G. Bolan, N. Padian, and J. Schachter. 1995. Major outer membrane protein variants of Chlamydia trachomatis are associated with severe upper genital tract infections and histopathology in San Francisco. J. Infect. Dis. 172:1013-1022[Medline]. |
| 8. | Frost, E. H., S. Deslandes, S. Veilleux, and D. Bourgaux-Ramoisy. 1991. Typing Chlamydia trachomatis by detection of restriction fragment length polymorphism in the gene encoding the major outer membrane protein. J. Infect. Dis. 163:1103-1107[Medline]. |
| 9. | Kuo, C.-C., S.-P. Wang, K. K. Holmes, and J. T. Grayston. 1993. Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect. Immun. 41:865-868. |
| 10. |
Lampe, M. F.,
R. J. Suchland, and W. E. Stamm.
1993.
Nucleotide sequence of the variable domains within the major outer membrane protein gene from serovariants of Chlamydia trachomatis.
Infect. Immun.
61:213-219 |
| 11. | Lampe, M. F., K. G. Wong, and W. E. Stamm. 1995. Sequence conservation in the major membrane protein gene among Chlamydia trachomatis strains isolated from the upper and lower genital tract. J. Infect. Dis. 172:589-592[Medline]. |
| 12. | Lan, J., I. Melgers, C. J. L. M. Meijer, J. M. M. Walboomers, R. Roosendaal, C. Burger, O. Bleker, and A. J. C. van den Brule. 1995. Prevalence and serovar distribution of asymptomatic cervical Chlamydia trachomatis infections as determined by the highly sensitive PCR. J. Clin. Microbiol. 33:3194-3197[Abstract]. |
| 13. | Lan, J., A. van den Hoek, J. M. Ossewaarde, J. M. M. Walboomers, and A. J. C. van den Brule. 1995. Genotyping of Chlamydia trachomatis serovars derived from heterosexual partners and a detailed genomic analysis of serovar F. Genitourin. Med. 71:299-303[Medline]. |
| 14. |
Lan, J.,
J. M. Ossewaarde,
J. M. M. Walboomers,
C. J. L. M. Meijer, and A. J. C. van den Brule.
1994.
Improved PCR sensitivity for direct genotyping of Chlamydia trachomatis serovars by using a nested PCR.
J. Clin. Microbiol.
32:528-530 |
| 15. |
Lan, J.,
A. J. C. van den Brule,
D. J. Hemrika,
E. K. Risse,
J. M. M. Walboomers,
M. E. I. Schipper, and C. J. L. M. Meijer.
1995.
Chlamydia trachomatis and ectopic pregnancy: retrospective analysis of salpingectomy specimens, endometrial biopsies and cervical smears.
J. Clin. Pathol.
48:815-819 |
| 16. | Lee, H. H., M. A. Chemesky, J. Schachter, J. D. Burczak, W. W. Andrews, S. Muldoon, G. Leckie, and W. E. Stamm. 1995. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 345:213-216[CrossRef][Medline]. |
| 17. | Lin, J. S. L., S. P. Donegan, T. C. Heeren, M. Greenberg, E. E. Flaherty, R. Haivanis, X. H. Su, D. Dean, W. J. Newhall, J. S. Knapp, S. K. Sarafian, R. J. Rice, S. A. Morse, and P. A. Rice. 1998. Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners. J. Infect. Dis. 178:1707-1712[CrossRef][Medline]. |
| 18. | Morré, S. A., P. Sillekens, M. V. Jacobs, P. van Aarle, S. de Blok, B. van Gemen, J. M. M. Walboomers, C. J. L. M. Meijer, and A. J. C. van den Brule. 1996. RNA amplification by nucleic acid-based amplification with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples. J. Clin. Microbiol. 34:3108-3114[Abstract]. |
| 19. | Morré, S. A., P. Sillekens, M. V. Jacobs, S. de Blok, B. van Gemen, J. M. M. Walboomers, C. J. L. M. Meijer, and A. J. C. van den Brule. 1998. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA amplification by NASBA. J. Clin. Pathol. Mol. Pathol. 51:149-154[Abstract]. |
| 20. |
Morré, S. A.,
R. M. Moes,
I. G. M. Van Valkengoed,
A. J. P. Boeke,
J. T. M. van Eijk,
C. J. L. M. Meijer, and A. J. C. van den Brule.
1998.
Genotyping of Chlamydia trachomatis in urine specimen will facilitate large epidemiological studies.
J. Clin. Microbiol.
36:3077-3078 |
| 21. |
Morré, S. A.,
J. M. Ossewaarde,
J. Lan,
G. J. J. van Doornum,
J. M. M. Walboomers,
D. M. MacLaren,
C. J. L. M. Meijer, and A. J. C. van den Brule.
1998.
Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis.
J. Clin. Microbiol.
36:345-351 |
| 22. |
Morré, S. A.,
I. G. M. Van Valkengoed,
R. M. Moes,
A. J. P. Boeke,
C. J. L. M. Meijer, and A. J. C. Van den Brule.
1999.
Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests with urine specimens.
J. Clin. Microbiol.
37:3092-3096 |
| 23. | Naher, H., and D. Petzoldt. 1991. Serovar distribution of urogenital Chlamydia trachomatis isolates in Germany. Genitourin. Med. 67:114-116[Medline]. |
| 24. |
Newhall, W. J.,
V. P. Terho,
C. E. Wilde III,
B. E. Batteiger, and R. B. Jones.
1986.
Serovar determination of Chlamydia trachomatis isolates by using type-specific monoclonal antibodies.
J. Clin. Microbiol.
23:333-338 |
| 25. |
Ossewaarde, J. M.,
M. Rieffe,
A. de Vries,
R. P. Derksen-Nawrocki,
H. J. Hooft,
G. J. J. van Doornum, and A. M. van Loon.
1994.
Comparison of two panels of monoclonal antibodies for determination of Chlamydia trachomatis serovars.
J. Clin. Microbiol.
32:2968-2974 |
| 26. | Persson, K. 1990. Epidemiology of serovars of Chlamydia trachomatis, p. 559-562. In W. R. Bowie, H. D. Caldwell, R. D. Jones, et al. (ed.), Chlamydial infections, proceedings of the seventh International Symposium on Human Chlamydial Infections. Cambridge University Press, Cambridge, England. |
| 27. |
Rodrigues, P.,
B. de Berbeyrac,
K. Persson,
B. Dutilh, and C. Bebear.
1993.
Evaluation of molecular typing for epidemiological study of Chlamydia trachomatis genital infections.
J. Clin. Microbiol.
31:2238-2240 |
| 28. | Sayada, C., E. Denamur, J. Orfila, F. Catalan, and J. Elion. 1991. Rapid genotyping of the Chlamydia trachomatis major outer membrane protein by the polymerase chain reaction. FEMS Microbiol. Lett. 83:73-78[CrossRef]. |
| 29. | Stary, A. S., S. Tomazic-Allen, B. Choueiri, J. Burczak, K. Steyer, and H. Lee. 1996. Comparison of DNA amplification methods for the detection of Chlamydia trachomatis in first-void urine from asymptomatic military recruits. Sex. Transm. Dis. 23:97-102[Medline]. |
| 30. | Van de Hoek, J. A. R., D. K. F. Mulder-Folkerts, R. A. Coutinho, N. H. T. M. Dukers, M. Buimer, and G. J. J. van Doornum. 1999. Opportunistische screening op genitale infecties met Chlamydia trachomatis onder de sexueel actieve bevolking in Amsterdam. Meer dan 90% deelname en bijna 5% prevalentie. Ned. Tijdschr. Geneeskd. 143:668-672[Medline]. |
| 31. | Van de Laar, M. J. W., J. Lan, Y. T. H. P. van Duynhoven, J. S. A. Fennema, J. M. Ossewaarde, A. J. C. van den Brule, G. J. J. van Doornum, R. A. Coutinho, and J. A. R. van den Hoek. 1996. Differences in clinical manifestations of genital chlamydial infections related to serovars. Genitourin. Med. 72:261-265[Medline]. |
| 32. | Van Duynhoven, Y. T. H. P., J. M. Ossewaarde, R. P. Derksen-Nawrocki, W. I. Van der Meijden, and M. J. W. Van de Laar. 1998. Chlamydia trachomatis genotypes: correlation with clinical manifestations and patients' characteristics. Clin. Infect. Dis. 26:314-322[Medline]. |
| 33. | Van Valkengoed, I. G. M., A. J. P. Boeke, A. J. C. van den Brule, S. A. Morré, J. H. Dekker, C. J. L. M. Meijer, and J. T. M. van Eijk. 1999. Systematische vroege opsporing van Chlamydia trachomatis infectioes bij asymptomatische jonge mannen en vrouwen via de huisartspraktijk. Ned. Tijdschr. Geneeskd. 143:672-676[Medline]. |
| 34. | Wagenvoort, J. H. T., R. J. Suchland, and W. E. Stamm. 1988. Serovar distribution of urogenital Chlamydia trachomatis strains in The Netherlands. Genitourin. Med. 64:159-161[Medline]. |
| 35. | Workowski, K. A., R. J. Suchland, M. B. Pettinger, W. E. Stamm, and K. K. Holmes. 1981. Chlamydia trachomatis proctitis. N. Engl. J. Med. 305:195-200[Abstract]. |
| 36. | Workowski, K. A., C. E. Stevens, R. J. Suchland, K. K. Holmes, D. H. Eschenbach, M. B. Pettinger, and W. E. Stamm. 1993. Clinical manifestations of genital infection due to Chlamydia trachomatis: differences related to serovar. Clin. Infect. Dis. 31:2238-2240. |
| 37. | Yang, C. L., I. Maclean, and R. C. Brunham. 1993. DNA sequence polymorphism of the Chlamydia trachomatis omp1 gene. J. Infect. Dis. 168:1225-1230[Medline]. |
| 38. |
Yuan, Y.,
X. Y. Zhang,
N. G. Watkins, and H. D. Caldwell.
1989.
Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane protein of the 15 Chlamydia trachomatis serovars.
Infect. Immun.
57:1040-1049 |
Journal of Clinical Microbiology, June 2000, p. 2292-2296, Vol. 38, No. 6
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Petrovay, F., Balla, E., Nemeth, I., Gonczol, E.
(2009). Genotyping of Chlamydia trachomatis from the endocervical specimens of high-risk women in Hungary. J Med Microbiol
58: 760-764
[Abstract] [Full Text] -
Gomes, J. P., Bruno, W. J., Nunes, A., Santos, N., Florindo, C., Borrego, M. J., Dean, D.
(2007). Evolution of Chlamydia trachomatis diversity occurs by widespread interstrain recombination involving hotspots. Genome Res
17: 50-60
[Abstract] [Full Text] -
den Hartog, J.E., Morre, S.A., Land, J.A.
(2006). Chlamydia trachomatis-associated tubal factor subfertility: immunogenetic aspects and serological screening. Hum Reprod Update
12: 719-730
[Abstract] [Full Text] -
Xiong, L., Kong, F., Zhou, H., Gilbert, G. L.
(2006). Use of PCR and Reverse Line Blot Hybridization Assay for Rapid Simultaneous Detection and Serovar Identification of Chlamydia trachomatis. J. Clin. Microbiol.
44: 1413-1418
[Abstract] [Full Text] -
Hsu, M.-C., Tsai, P.-Y., Chen, K.-T., Li, L.-H., Chiang, C.-C., Tsai, J.-J., Ke, L.-Y., Chen, H.-Y., Li, S.-Y.
(2006). Genotyping of Chlamydia trachomatis from clinical specimens in Taiwan.. J Med Microbiol
55: 301-308
[Abstract] [Full Text] -
Lyons, J M, Ito, J I Jr, Pena, A S, Morre, S A
(2005). Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum. J. Clin. Pathol.
58: 397-401
[Abstract] [Full Text] -
Molano, M., Meijer, C. J. L. M., Morre, S. A., Pol, R., van den Brule, A. J. C.
(2004). Combination of PCR Targeting the VD2 of omp1 and Reverse Line Blot Analysis for Typing of Urogenital Chlamydia trachomatis Serovars in Cervical Scrape Specimens. J. Clin. Microbiol.
42: 2935-2939
[Abstract] [Full Text] -
Lister, N. A, Tabrizi, S. N., Fairley, C. K., Smith, A., Janssen, P. H., Garland, S.
(2004). Variability of the Chlamydia trachomatis omp1 Gene Detected in Samples from Men Tested in Male-Only Saunas in Melbourne, Australia. J. Clin. Microbiol.
42: 2596-2601
[Abstract] [Full Text] -
Spaargaren, J, Verhaest, I, Mooij, S, Smit, C, Fennema, H S A, Coutinho, R A, Salvador Pena, A, Morre, S A
(2004). Analysis of Chlamydia trachomatis serovar distribution changes in the Netherlands (1986-2002). Sex. Transm. Infect.
80: 151-152
[Full Text] -
Hosseinzadeh, S., Eley, A., Pacey, A. A.
(2004). Semen Quality of Men With Asymptomatic Chlamydial Infection. J Androl
25: 104-109
[Abstract] [Full Text] -
Ngandjio, A., Clerc, M., Fonkoua, M. C., Thonnon, J., Lunel, F., Bebear, C., Bianchi, A., de Barbeyrac, B.
(2004). Restriction endonuclease patterns of the omp1 gene of reference Chlamydia trachomatis strains and characterization of isolates from Cameroonian students. J Med Microbiol
53: 47-50
[Abstract] [Full Text] -
Murillo, L. S., Land, J. A., Pleijster, J., Bruggeman, C. A., Pena, A. S., Morre, S. A.
(2003). Interleukin-1B (IL-1B) and interleukin-1 receptor antagonist (IL-1RN) gene polymorphisms are not associated with tubal pathology and Chlamydia trachomatis-related tubal factor subfertility. Hum Reprod
18: 2309-2314
[Abstract] [Full Text] -
Ngandjio, A., Clerc, M., Fonkoua, M. C., Thonnon, J., Njock, F., Pouillot, R., Lunel, F., Bebear, C., de Barbeyrac, B., Bianchi, A.
(2003). Screening of Volunteer Students in Yaounde (Cameroon, Central Africa) for Chlamydia trachomatis Infection and Genotyping of Isolated C. trachomatis Strains. J. Clin. Microbiol.
41: 4404-4407
[Abstract] [Full Text] -
Hosseinzadeh, S., Pacey, A.A., Eley, A.
(2003). Chlamydia trachomatis-induced death of human spermatozoa is caused primarily by lipopolysaccharide. J Med Microbiol
52: 193-200
[Abstract] [Full Text] -
Stothard, D. R.
(2001). Use of a Reverse Dot Blot Procedure To Identify the Presence of Multiple Serovars in Chlamydia trachomatis Urogenital Infection. J. Clin. Microbiol.
39: 2655-2659
[Abstract] [Full Text] -
Gravitt, P. E., Castle, P. E., Smith, J. S., Munoz, N., Franceschi, S., Eluf-Neto, J., Herrero, R., Peeling, R. W., Morre, S. A., Ossewaarde, J. M., Numazaki, K., Ikehata, M., Chiba, S., Anttila, T., Koskela, P., Lehtimen, M., Dillner, J., Paavonen, J.
(2001). Chlamydia trachomatis and Cervical Squamous Cell Carcinoma. JAMA
285: 1703-1706
[Full Text] -
Hosseinzadeh, S., Brewis, I.A., Eley, A., Pacey, A.A.
(2001). Co-incubation of human spermatozoa with Chlamydia trachomatis serovar E causes premature sperm death. Hum Reprod
16: 293-299
[Abstract] [Full Text] -
Morré, S. A., Ossewaarde, J. M., Savelkoul, P. H. M., Stoof, J., Meijer, C. J. L. M., van den Brule, A. J. C.
(2000). Analysis of Genetic Heterogeneity in Chlamydia trachomatis Clinical Isolates of Serovars D, E, and F by Amplified Fragment Length Polymorphism. J. Clin. Microbiol.
38: 3463-3466
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»